Biodexa Pharmaceuticals Plc (BDRX)
3.24
+0.13
(+4.18%)
USD |
NASDAQ |
May 21, 16:00
3.23
-0.01
(-0.31%)
After-Hours: 19:59
Biodexa Pharmaceuticals Research and Development Expense (TTM) : 5.234M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| NuCana Plc | 19.05M |
| Autolus Therapeutics Plc | 112.24M |
| Mereo BioPharma Group Plc | 18.61M |
| Bicycle Therapeutics Plc | 262.21M |
| Amarin Corp. Plc | 16.24M |